Raymond W. Nims

RMC Pharmaceutical Solutions, Inc.

Raymond Nims has more than 37 years of experience in the biomedical sciences. He currently provides consulting services as an employee of RMC Pharmaceutical Solutions. From 2006 to 2009, Dr. Nims served in Amgen’s corporate quality control group, providing subject matter expertise in viral and mycoplasma testing of raw materials and products, and serving as business process owner for Amgen’s global contract analytical testing lab outsourcing program. From 1994 to 2006, he directed laboratories at BioReliance, performing viral safety, endotoxin, and cell-line identity studies for biologics cell-line characterization, raw material testing, and product lot release testing. From 1985 to 1994, he served as a chemist at the National Cancer Institute’s Laboratory of Chemical Carcinogenesis. Dr. Nims obtained a Ph.D. in Chemistry (Chemical Toxicology) at The American University, Washington, DC, in 1993. He currently serves on the editorial board for BioProcessing Journal and has served on the ad hoc advisory boards for USP chapters 1237, 1050, and 1050.1. He is a generalist in the biomedical sciences, with a publication list spanning a wide range of topics in chemistry, carcinogenesis, biochemistry, pharmacology, toxicology, and virology.

1books edited

2chapters authored

Latest work with IntechOpen by Raymond W. Nims

Each of the chapters in Disinfection of Viruses touches on virucidal efficacy for SARS-CoV-2, the causative agent for the COVID-19 disease, or enveloped viral surrogates. SARS-CoV-2 is an enveloped virus of the Coronaviridae family and therefore is expected to be susceptible to all classes of microbicides. The book is divided into three sections. Section 1: “Microbicides for Viral Inactivation,” includes chapters on the efficacy of chemical virucides, Section 2: “Physical Inactivation Approaches,” includes a chapter on the efficacy of gamma irradiation, ultraviolet light, and heat for inactivating coronaviruses, and Section 3: “Viral Persistence and Disinfection,” includes data on viral persistence for SARS-CoV-2, as these data inform the need for and the approaches that might be used for disinfection.

Go to the book